DistriPhil | Pharmaceutical Company Philippines | Healthcare Solutions

pharmaceutical company philippines

pharmaceutical services philippines

healthcare solutions philippines

pharmaceutical marketing

pharmaceutical products philippines

healthcare logistics
pharmaceutical industry

News And Insights

Distriphil Forges Partnership With Sandoz To Promote And Distribute Frepan®

Poised to strengthen its footprint in the ethical pharmaceutical business, Distribution Solutions Philippines Inc. (DISTRIPHIL), has recently embarked a partnership with Sandoz Philippines Corporation-A Novartis Company, to exclusively handle the ethical promotion and distribution of one of their key drug products, Frepan®, in the Philippines.

Frepan® is Sandoz’s brand of Candesartan cilexetil, an angiotensin II receptor blocker (ARB). ARBs constitute a group of drugs which are widely used in the treatment of hypertension. Frepan® is a prescription drug indicated for the treatment of essential hypertension in adults, treatment of hypertension in children and adolescents aged 6 years to less than 18 years, and the treatment of adult patients with heart failure and impaired left ventricular systolic function. It is available in the Philippines in 8-milligram and 16-milligram tablet preparations. 

This same partnership also granted DISTRIPHIL the right to exclusively handle the ethical promotion and distribution of Prostera®, which is Sandoz’s brand of Terazosin hydrochloride. Prostera® is a prescription drug used among patients with benign prostatic hyperplasia.

In the Philippines, it is estimated that 18% of Filipino adults have elevated blood pressure, based on the 2013 National Nutrition and Health Survey of the Department of Science and Technology-Food and Nutrition Research Institute (DOST-FNRI). [3] Related to this, ischemic heart disease and cardiovascular diseases remain to be among the leading causes of death in the country. [4] Thus, improved access to cardiovascular medications, coupled with patient education with emphasis healthy lifestyle and compliance to medications are viewed to be vital in curbing this health concern.

Sandoz is the generics division of the globally-recognized multinational pharmaceutical company Novartis. With this partnership, SANDOZ and DISTRIPHIL mutually affirms its commitment to continuously provide relevant, high-quality and affordable medicines and health solutions for Filipino patients.

DISTRIPHIL is a national pharmaceutical company and part of the Chiongbian Group of Companies. For more information about DISTRIPHIL’s products and services, you may reach our Business Development Unit through our Contact Us Page or you may send us an email through info@distriphil.com.

References:

  1. Candesartan (Frepan®®) Product Insert. (2019). Sandoz Philippines Corporation. Makati City, Philippines.
  2. Terazosin HCl hydrochloride (Prostera®) Product Insert. (2014). Sandoz Philippines Corporation. Makati City, Philippines.
  3. Food and Nutrition Research Institute-Department of Science and Technology (FNRI-DOST). 2015. Philippine Nutrition Facts and Figures 2013: Clinical and Health Survey. FNRI Bldg., DOST Compound, Bicutan, Taguig City, Metro Manila, Philippines.
  4. Philippine Statistics Authority. Registered Deaths in the Philippines, 2017. https://psa.gov.ph/vital-statistics/id/138794

DISCLAIMER: The information presented in this webpage are purely for informational purposes only and does not constitute nor intends to replace the advice of a medical professional. Your doctor is the best person to assess your medical condition and determine which medicines and/or products are best suited for your needs. Please consult your doctor before using any product or medication.